Your browser doesn't support javascript.
loading
Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis.
Burmester, Gerd R; Coates, Laura C; Cohen, Stanley B; Tanaka, Yoshiya; Vranic, Ivana; Nagy, Edward; Lazariciu, Irina; Chen, All-Shine; Kwok, Kenneth; Fallon, Lara; Kinch, Cassandra.
Afiliação
  • Burmester GR; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Coates LC; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Oxford, UK.
  • Cohen SB; Metroplex Clinical Research Center and Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Tanaka Y; First Department of Internal Medicine, University of Occupational and Environmental Health Japan, Kitakyushu, Japan.
  • Vranic I; Pfizer Ltd, Tadworth, UK.
  • Nagy E; Pfizer Ltd, Tadworth, UK.
  • Lazariciu I; Pfizer Inc, New York, NY, USA.
  • Chen AS; Pfizer Inc, Groton, CT, USA.
  • Kwok K; Pfizer Inc, New York, NY, USA.
  • Fallon L; Inflammation and Immunology, Pfizer Canada ULC, 17300 Trans-Canada Hwy, Kirkland, QC, H9J 2M5, Canada.
  • Kinch C; Inflammation and Immunology, Pfizer Canada ULC, 17300 Trans-Canada Hwy, Kirkland, QC, H9J 2M5, Canada. cassandra.kinch@pfizer.com.
Rheumatol Ther ; 11(1): 221-222, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38041731

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article